Showing results (161-170 of 237) with videos related to

Sort By:
Pageof 24
Plos One|August 31, 2016
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk PredictionMichele Pohlen, Nils H Thoennissen, Jan Braess, et al.
British Journal of Haematology|April 4, 2017
Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationFrancesco Onida, Liesbeth C de Wreede, Anja van Biezen, et al.
Blood Advances|April 25, 2022
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapseAndrew F Berdel, Leo Ruhnke, Linus Angenendt, et al.
Blood Advances|October 5, 2024
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in GermanyAysenur Arslan, Svenja Labuhn, Elisa Sala, et al.
Blood|January 15, 2020
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors failsJohannes Schetelig, Henning Baldauf, Falk Heidenreich, et al.
Plos One|January 3, 2018
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk PredictionMichele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2018
Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation StudySalyka Sengsayadeth, Myriam Labopin, Ariane Boumendil, et al.
The Lancet. Oncology|September 11, 2012
Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trialMartin Bornhäuser, Joachim Kienast, Rudolf Trenschel, et al.
Bone Marrow Transplantation|April 25, 2024
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, et al.
Transplantation and Cellular Therapy|August 28, 2022
Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic LeukemiaDietrich W Beelen, Renate Arnold, Matthias Stelljes, et al.
Pageof 24